Abstract
The major forms of obstructive lung disease are bronchial asthma and chronic obstructive pulmonary disease (COPD). Asthma is characterized by a predominantly functional bronchial obstruction that is almost entirely reversible, at least at early stages; COPD exposes structural changes and deficits of the respiratory tract, including the lung tissue, that are mostly irreversible. COPD is the typical and most prevalent chronic lung disease of the elderly, while new asthma will rarely occur, and existing asthma usually becomes milder at higher age. Therefore, the focus of this chapter is drug treatment of COPD in the elderly. Unfortunately, the epidemiological significance of COPD is not adequately recognized even today. Yet, the incidence will sharply rise in the future, and it is assumed that in 2030 COPD will be the third-most-important cause of death globally, only secondary to cardiovascular diseases and AIDS (Table 1). This epidemic reflects the aging of Western societies as COPD is an age-related disease and the lack of success against the main avoidable culprit, which is smoking, causing about 80–90 % of all COPD-related deaths. Although in the United States smoking is on the decline, the increasing prevalence of smoking in women partly compensates for the success. It is assumed that in 2008 there will be 12 million U.S. citizens who suffer from COPD (American Lung Association 2010), with an estimated equal number of undiagnosed cases. The prevalence of COPD in elderly U.S. citizens aged 65+ years was around 10 % in 2000 (Mannino et al. 2002) and should have risen in between. In patients aged 70+ years in Salzburg, Austria, the prevalence was at 50 % (Schirnhofer et al. 2007).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Lung Association (2010) Trends in COPD (chronic bronchitis and emphysema): morbidity and mortality. American Lung Association Epidemiology and Statistics Unit, Research and Program Services Division. http://www.lungusa.org/finding-cures/our-research/trend-reports/copd-trend-report.pdf. Accessed 20 Jul 2011
Board M, Allen SC (2006) A simple drawing test to identify patients who are unlikely to be able to learn to use an inhaler. Int J Clin Pract 60:510–513
Buhl R, Berdel D, Criee CP et al (2006) Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma. Pneumologie 60:139–177
Centers for Disease Control and Prevention (CDC) (2006) Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years—United States, 2004–2005. MMWR Morb Mortal Wkly Rep 55:1065–1068
Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2010). Global Strategy for the Diagnosis, Management and Prevention of COPD, http://www.goldcopd.org/uploads/users/files/GOLDReport_April112011.pdf. Accessed 27 Jun 2012
Jara M, Lanes SF, Wentworth C 3rd, May C, Kesten S (2007) Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database. Drug Saf 30:1151–1160
Mannino DM, Homa DM, Akinbami LJ et al (2002) Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. MMWR Surveill Summ 51:1–16
Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442
Muller D, Szucs TD (2007) Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05. Infection 35:308–319
Rabe KF, Hurd S, Anzueto A et al (2007) Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532–555
Salpeter SR (2007) Bronchodilators in COPD: impact of betaagonists and anticholinergics on severe exacerbations and mortality. Int J Chron Obstruct Pulmon Dis 2:11–18
Schirnhofer L, Lamprecht B, Vollmer WM, Allison MJ, Studnicka M, Jensen RL, Buist AS (2007) COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) study. Chest 131:29–36
van Weel C (1996) Chronic diseases in general practice: the longitudinal dimension. Eur J Gen Pract 2:17–21
Vogelmeier C, Hederer B, Glaab T et al (2011) Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 364:1093–1103
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Wehling, M. (2013). Obstructive Lung Diseases. In: Wehling, M. (eds) Drug Therapy for the Elderly. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0912-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0912-0_11
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0911-3
Online ISBN: 978-3-7091-0912-0
eBook Packages: MedicineMedicine (R0)